17.60
Finanzdaten der Seaport Therapeutics Inc-Aktie (SPTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 |
| Periodenlänge | 3 Monate | 3 Monate |
| Operating Expenses |
138.93%
65.81
|
27.54 |
| Operating Income/Loss |
138.93%
-65.81
|
-27.54 |
| Nonoperating Income/Loss |
30.33%
3.459
|
2.654 |
| Income/Loss From Continuing Operations Before Tax |
150.51%
-62.35
|
-24.89 |
| Income Tax Expense/Benefit |
51.64%
0.251
|
0.519 |
| Net Income/Loss |
146.38%
-62.60
|
-25.41 |
| Basic Average Shares |
1,334%
35.24
|
2.4568 |
| Diluted Average Shares |
1,334%
35.24
|
2.4568 |
| Basic Earnings Per Share |
82.79%
-1.78
|
-10.34 |
| Diluted Earnings Per Share |
82.79%
-1.78
|
-10.34 |
| Common Stock Dividends |
-
|
- |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):